National survey about the aggravation by respiratory syncytial virus infection in children with immunodeficiency

National survey about the aggravation by respiratory syncytial virus infection in children with immunodeficiency - National survey about trespiratory syncytial virus infection in children with immunodeficiency

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020464

Enrollment

500

Registered

2016-02-01

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory syncytial virus (RSV)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: There is a medical treatment record during the period of from April, 2010 to March, 2015 and does an affected child entering three following categories among 0-5 years old within children at some point during the period with criteria for selection. -Under the immunosuppressive therapy enforcement during the high-dose steroid therapy enforcement (rheumatic diseases, collagen diseases, renal diseases) -Down's syndrome (except the congenital heart failure (CHD)) -After organ transplantation

Exclusion criteria

Exclusion criteria: Except the above

Design outcomes

Primary

Measure	Time frame
Change of the rate of hospitalization by RSV	—

Secondary

Measure	Time frame
Change of the rate of hospitalization by the RSV infection aggravation, and Rate of hospitalization at the age that is higher than a child targeted for adaptation	—

Countries

Japan

Contacts

Public ContactMasaaki Mori

Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University Department of Clinical Immunology

mori.phv@tmd.ac.jp+81-3-5803-4876

Outcome results